PharmaQo Primobolan 5 – 5 mg Methenolone Acetate Oral Tablets (100 Tablets)

Customer Review 0
5/5

£ 28.50

PharmaQo Primobolan 5 delivers 5 mg Methenolone Acetate per oral tablet, studied for mild anabolic effects, low androgenic activity, and lean tissue preservation. Used in research on muscle-wasting, nitrogen balance, and recovery. Not approved for human use.

Quantity Discounts

QuantityPrice
0 - 49£ 28.50
50 - 99£ 25.65
100 - 249£ 24.23
250 +£ 22.80
Share it :
Payment-Icon.png
International Shipment

Your orders are shipped seamlessly between countries

30 Days Warranty

You have the right to return your orders within 30 days.

Secure Payment

Your payments are secure with our private security network.

Description

PharmaQo Primobolan 5 provides 5 mg Methenolone Acetate per oral tablet, packaged in 100-tablet units for research purposes. Methenolone Acetate is studied for its mild anabolic effects, low androgenic activity, and applications in muscle-wasting, nitrogen balance, and recovery models.

With minimal liver toxicity and no estrogenic activity, it is a preferred compound in investigational studies focused on lean tissue preservation and metabolic effects.


Product Details:
Active Ingredient:

  • Methenolone Acetate (Primobolan)

Concentration: 5 mg per tablet

Form: Oral tablets

Packaging: 100 tablets per pack


Pharmacokinetics:
Methenolone Acetate has an oral half-life of ~6 hours, requiring daily or divided dosing in research designs.


Usage Recommendations:

  • Indications (Research Context): Investigational use in tissue preservation, nitrogen retention, and anabolic activity models (not approved for human use)

  • Typical Dosage (Research Use): 20–50 mg per day, depending on study

  • Monitoring: Lipid profile, liver enzymes, androgenic effects, cardiovascular markers

  • Cycle/Duration: 6–10 weeks under research protocols


Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical conditions. Always comply with local research laws and ethical standards.

error: Content is protected !!